Login

What is a CEO's day like? CEO X from Lassila & Tikanoja Oyj was live on June 13, 2017. 00:10:00

Share On Facebook Share On Twitter

Eero Ilmari Hautaniemi is Former President/CEO at Lassila & Tikanoja OY

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"JoAnn Price on Investing in Emerging Fund Managers | Fairview Capital Partners"
00:10:00
Arezzos Digital Transformation Amid the Pandemicn | Alexandre Birman, CEO, Arezzo Industria e Comercio SA.
00:10:00
Evolution of Ariana Minerals: From Nickel to Gold Focus
00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:10:00
Empowering Change: A Leader's Perspective on Making a Positive Impact for Our Planet | Alan Brookes - Chief Executive Officer and Chairman of Arcadis
00:10:00
Global Growth Perspectives: Insights from Michael Edmonds at Tradex AGM | Michael Edmonds - Portfolio Manager, City of London Investment Management
00:00:00
Fibrocell Science - Company Presentation - David Pernock, Chairman & CEO, Fibrocell Science Inc
00:10:00
Las Chispas Project: Unveiling High-Grade Silver and Gold Opportunities in Sonora, Mexico
00:10:00
Chart Industries CEO Jillian Evanko: Clean Energy Funding Insights | Jillian C. Evanko - CEO of Chart Industries, Inc.
00:10:00
Alexandre Guerrero on Eletromidia's Growth, Globo Partnership, and Future Prospects | Alexandre Guerrero , CEO , Eletromidia SA.
00:10:00
Per Lekander: Visionary Fund Manager at Lansdowne Partners
00:10:00
In this Q&A, John Belizaire, CEO of Soluna Holdings, Inc., answers shareholders' and potential investors' most asked questions..|John Belizaire is Chief Executive Officer & Director, Soluna Holdings, Inc.

© 2026 Nehu